Show simple item record

dc.contributor.authorDurukan, Elif
dc.contributor.authorOnal, Ozgur
dc.date.accessioned2019-04-25T12:23:14Z
dc.date.available2019-04-25T12:23:14Z
dc.date.issued2018
dc.identifier.issn1304-2947
dc.identifier.urihttp://geriatri.dergisi.org/uploads/pdf/pdf_TJG_1081.pdf
dc.identifier.urihttp://hdl.handle.net/11727/3081
dc.description.abstractIntroduction: Polypharmacy is common among the elderly. This study aimed to determine the frequency of polypharmacy and the risk factors in the elderly. Materials and Method: This cross-sectional study will be analysed in three stages (polypharmacy, drug characteristics and drug interaction). Herein, the first stage (polypharmacy) was conducted at Burdur city centre and the connected villages. A total of 400 of 11,360 subjects aged >= 65 years who were registered with family physicians in Burdur city centre were selected using a systematic sampling method. A questionnaire of 30 questions about socio-demographic variables and rational drug use was distributed among the subjects. Subsequently, the subjects were asked to bring their own drugs from home that they were actively using or not currently using, and their drug-using behaviour was analysed via specific questions. Results: The average number of different drugs possessed by the subjects at home was approximately 6 (5.95 +/- 4.30). A total of 64.9% of the drugs were used regularly, 21.3% were used occasionally and 13.8% were previously used but not currently used. The median number +/- standard deviation of the drugs that were used regularly, used occasionally and previously used but not currently used was 3.86 +/- 3.36, 1.27 +/- 1.75 and 0.82 +/- 1.82, respectively. According to the results of multivariate analysis, the presence of diabetes, hypertension, respiratory system or cardiovascular (except hypertension) diseases, visual impairment or hearing disorders significantly increased the total drug use (p<0.05). Conclusion: Chronic diseases and living in the city centre are the main risk factors leading to polypharmacy. Therefore, interventions must be undertaken by monitoring and reducing chronic diseases and providing training on rational drug use in the provincial centres.en_US
dc.language.isoengen_US
dc.relation.isversionof10.31086/tjgeri.2018.61en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPolypharmacyen_US
dc.subjectAgeden_US
dc.subjectChronicen_US
dc.subjectDiseaseen_US
dc.titleFREQUENCY OF POLYPHARMACY AND RISK FACTORS IN THE ELDERLYIN BURDURen_US
dc.typearticleen_US
dc.relation.journalTURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISIen_US
dc.identifier.volume21en_US
dc.identifier.issue4en_US
dc.identifier.startpage550en_US
dc.identifier.endpage556en_US
dc.identifier.wos000454634500012en_US
dc.identifier.scopus2-s2.0-85059245467en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record